Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cuihong Lian
Institutions:
Guangxi University of Chinese Medicine,
Shenzhen University Health Science Center,
Shenzhen Second People's Hospital
Observed institutions:
Guangxi University of Chinese Medicine,
Shenzhen University Health Science Center,
Shenzhen Second People's Hospital
ORCID:
0000-0003-0377-0564
Observed ORCID:
0000-0003-0377-0564
OpenAlex ID:
A5103014157
Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study
2026
·
Maoying Li
, Cuihong Lian
, et al.
·
World Allergy Organization Journal
·
2
PDF
Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
2026
·
Maoying Li
, Xi Wang
, et al.
·
Clinical Cosmetic and Investigational Dermatology
·
1
PDF
Corrigendum to “Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study” [World Allergy Organ J 16 (2) (2023) 101167]
2026
·
Maoying Li
, Cuihong Lian
, et al.
·
World Allergy Organization Journal
PDF
Off‐Label Use of Selective JAK1 Inhibitors in Immune‐Mediated Inflammatory Skin Diseases: A Retrospective Case Series
2026
·
Si Zhang
, Xinnuo Chen
, et al.
·
Dermatologic Therapy
Show more works
View as search
Works count:
4
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type